Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |